Trials / Sponsors / Pari Pharma GmbH
Pari Pharma GmbH
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis Rhinosinusitis | Phase 1 / Phase 2 | 2015-10-27 |
| Completed | Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects Cystic Fibrosis | Phase 1 | 2013-09-01 |
| Completed | Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi Rhinosinusitis, Chronic Polyposis | Phase 1 / Phase 2 | 2013-08-28 |
| Terminated | Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Bronchiolitis Obliterans | Phase 3 | 2012-02-01 |
| Terminated | L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients Bronchiolitis Obliterans | Phase 2 / Phase 3 | 2009-12-01 |